PFBT
HZNP

Parkside Financial Bank & Trust’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Parkside Financial Bank & Trust’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-77
Closed -$8.91K – 2221
2023
Q3 		$8.91K Sell
77
-10
-11% -$1.07K ﹤0.01% 1162
2023
Q2 		$8.95K Hold
87
– – ﹤0.01% 1159
2023
Q1 		$9.5K Sell
87
-18
-17% -$1.99K ﹤0.01% 1125
2022
Q4 		$11.9K Buy
105
+18
+21% +$1.5K ﹤0.01% 1004
2022
Q3 		$5K Sell
87
-185
-68% -$12.9K ﹤0.01% 1260
2022
Q2 		$22K Sell
272
-141
-34% -$13.4K 0.01% 795
2022
Q1 		$43K Sell
413
-71
-15% -$6.92K 0.01% 588
2021
Q4 		$52K Sell
484
-58
-11% -$6.33K 0.01% 523
2021
Q3 		$60K Buy
542
+11
+2% +$1.14K 0.02% 462
2021
Q2 		$50K Buy
531
+3
+0.6% +$276 0.01% 503
2021
Q1 		$48K Hold
528
– – 0.01% 504
2020
Q4 		$39K Sell
528
-3
-0.6% -$223 0.01% 534
2020
Q3 		$41K Buy
531
+18
+4% +$1.24K 0.01% 457
2020
Q2 		$29K Buy
513
+45
+10% +$1.93K 0.01% 545
2020
Q1 		$14K Buy
468
+72
+18% +$2.44K 0.01% 654
2019
Q4 		$14K Buy
396
+359
+970% +$11K ﹤0.01% 749
2019
Q3 		$1K Buy
+37
New +$957 ﹤0.01% 1544

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Parkside Financial Bank & Trust's HZNP Position: Q4 2023 in Review

Parkside Financial Bank & Trust sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 77 shares — an estimated $8.91K sold.

Parkside Financial Bank & Trust first reported a position in HZNP in Q3 2019 and held it in 17 quarters. The position peaked at $60K in Q3 2021. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Parkside Financial Bank & Trust reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 77 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $8.91K.
  • Parkside Financial Bank & Trust first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2019 and held it in 17 quarters.
  • Parkside Financial Bank & Trust's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $60K in Q3 2021.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Parkside Financial Bank & Trust's 13F filing for Q4 2023, filed 1 Feb 2024.